Autochthonous hepatitis e virus infection in Europe: A matter of concern for public health?

Journal of Clinical and Translational Hepatology

Volumn 2, Issue 1, 2014, Pages 7-14

  Echevarría, José Manuel ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Epidemiology; Europe; Hepatitis; Hepatitis E virus; Human

Indexed keywords

EID: 84977903301     PISSN: 22250719     EISSN: 23108819     Source Type: Journal    
DOI: 10.14218/JCTH.2013.00027     Document Type: Review

References (64)

1. Smith DB, Purdy MA, Simmonds P. Genetic variability and the classification of hepatitis E virus. J Virol 2013;87:4161–4169.
2. Holla RP, Ahmad I, Ahmad Z, Jameel S. Molecular virology of hepatitis E virus. Sem Liver Dis 2013;33:3–14.
3. Dalton HR, Stableforth W, Hazeldine S, Thurairajah P, Ramnarace R, Warshow U, et al. Autochthonous hepatitis E in Southwest England: a comparison with hepatitis A. Eur J Clin Microbiol Infect Dis 2008;27:579– 585.
4. Said B, Ijaz S, Kafatos G, Booth L, Thomas HL, Walsh A, et al. Hepatitis E outbreak on cruise ship. Emerg Infect Dis 2009;15:1738–1744.
5. Kamar N, Rostaing L, Izopet J. Hepatitis E virus infection in immunossu-pressed patients: natural history and therapy. Sem Liver Dis 2013;33:62– 70.
6. Drobeniuc J, Greene-Montfort T, Le N-T, Mixson-Hayden TR, Ganova-Raeva L, Dong C, Novak RT, et al. Laboratory-based surveillance for hepatitis E virus infection, United States, 2005–2012. Emerg Infect Dis 2013;19:218–222.
7. Echevarría JM, González JE, Lewis-Ximénez LL, Lopes dos Santos DR, Munné MS, Pinto MA, et al. Hepatitis E virus infection in Latin America: a review. J Med Virol 2013;85:1037–1045.
8. Echevarría JM. Light and darkness: prevalence of hepatitis E virus infection among the general population. Scientifica, in press.
9. Kuniholm MH, Purcell RH, McQuillan GM, Engle RE, Wasley A, Nelson KE. Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988–1994. J Infect Dis 2009;200:48–56.
10. Fogeda M, de Ory F, Avellón A, Echevarría JM. Differential diagnosis of hepatitis E virus, cytomegalovirus and Epstein-Barr virus infection in patients with suspected hepatitis E. J Clin Virol 2009;45:259–261.
11. Ijaz S, Arnold E, Banks M, Bendall RP, Cramp ME, Cunningham R, et al. Non-travel-associated hepatitis E in England and Wales: demographic, clinical, and molecular epidemiological characteristics. J Infect Dis 2005;192:1166– 1172.
12. Lewis HC, Boisson S, Ijaz S, Hewitt K, Ngui SL, Boxall E, et al. Hepatitis E in England and Wales. Emerg Infect Dis 2008;14:165–167.
13. Wichmann O, Schimanski S, Koch J, Kohler M, Rothe C, Plentz A, et al. Phylogenetic and case-control study on hepatitis E virus infection in Germany. J Infect Dis 2008;198:1732–1741.
14. Romanò L, Paladini S, Tagliacarne C, Canuti M, Bianchi S, Zanetti AR. Hepatitis E in Italy: a long-term prospective study. J Hepatol 2011;54:34– 40.
15. Candido A, Taffon S, Chionne P, Pisani G, Madonna E, Dettori S, et al. Diagnosis of HEV infection by serological and real-time PCR assays: a study on acute non-A-Chepatitis collected from 2004 to 2010 in Italy. BMC Res Notes 2012;5:297.
16. Echevarría JM, Fogeda M, Avellón A. Diagnosis of acute hepatitis E by antibody and molecular testing: a studyon 277 suspected cases. J Clin Virol 2011;50:69–71.
17. Mateos ML, Díez M, González-Galdameza A,Graus J, Moreno A, Pérez-Gracia MT. Acute, chronic and fulminant hepatitis E: seven years of experience (2004–2011). Enferm Infecc Microbiol Clin 2013;31:595–598.
18. Echevarría JM, Fogeda M, Avellón A. Update of cases of acute hepatitis E confirmed by the National Centre of Microbiology (Spain, 2004–2011). Enferm Infecc Microbiol Clin 2013;31:57–61.
19. Kantala T, Maunula L, von Bonsdorff CH, Peltomaa J, Lappalainen M. Hepatitis E virus in patients with unexplained hepatitis in Finland. J ClinVirol 2009; 45: 109–113.
20. Widén F, Sundqvist L, Matyi-Toth A, Metreveli G, Belák S, Hallgren G, et al. Molecular epidemiology of hepatitis E virus in humans, pigs and wild boars in Sweden. Epidemiol Infect 2011;139:361–371.
21. Pina S, Jofre J, Emerson SU, Purcell RH, Gironés R. Characterization of a strain of infectious hepatitis E virus isolated from sewage in an area where hepatitis E is not endemic. Appl Environ Microbiol 1998;64:4485–4488.
22. Clemente-Casares P, Rodríguez-Manzano J, Gironés R. Hepatitis E virus genotype 3 and sporadically also genotype 1 circulate in the population of Catalonia, Spain. J Water Health 2009;7:664–673.
23. La Rosa G, Pourshaban M, Iaconelli M, Spuri V, Muscillo M. Molecular detection of hepatitis E virus in sewage samples. Appl Environ Microbiol 2010;76:5870–5873.
24. Díez-Valcarce M, Kokkinos P, Söderberg K, Bouwknegt M, Willems K, de Roda-Husman AM, et al. Occurrence of human enteric viruses in commercial mussels at retail level in three European countries. Food Environ Virol 2012; 4:73–80.
25. De Silva AN, Muddu AK, Iredale JP, Sheron N, Khakoo SI, Pelosi E. Unexpectedly high incidence of indigenous acute hepatitis E within South Hampshire: time for routine testing? J Med Virol 2008;80:283–288.
26. Reuter G, Fodor D, Forgách P, KátaiA, Szucs G. Characterization and zoonotic potential of endemic hepatitis E virus (HEV) strains in humans and animals in Hungary. J ClinVirol 2009;44:277–281.
27. Mansuy JM, Péron JM, Abravanel F, Poirson H, Dubois M, Miedouge M, et al. Hepatitis E in the southwest of France in individuals who have never visited an endemic area. J Med Virol 2004;74:419–424.
28. Herremans M, Bakker J, Duizer E, Vennema H, Koopmans MP. Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity. Clin Vaccine Immunol 2007;14: 562–568.
29. Slot E, Hogema BM, Riezebos-Brilman A, Kok TM, Molier M, Zaaijer HL. Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012. Euro Surveill 2013;18:1–7.
30. Juhl D, Baylis SA, Blümel J, Görg S, Hennig H. Seroprevalence and incidence of hepatitis E virus infection in German blood donors.Transfusion, in press.
31. Kamar N, Bendall RP, Péron JM, Cintas P, Prudhomme L, Mansuy JM, et al. Hepatitis E virus and neurologic disorders. Emerg Infect Dis 2011;17:173– 179.
32. Despierres LA, KaphanE,Attarian S, Cohen-Bacrie S, Pelletier J, Pouget J, et al. Neurologic disorders and hepatitis E, France, 2010. Emerg Infect Dis 2011;17:1510–1512.
33. Moal V, Legris T, Burtey S, Morange S, Purgus R, Dussol B, et al. Infection with hepatitis E virus in kidney transplant recipients in Southeastern France. J Med Virol 2013;85:462–471.
34. Haagsma E, van den Berg AP, Porte RJ, Benne CA, Vennema H, Reimerink JHJ, et al. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transplant 2008;14:547–553.
35. Pischke S, Stiefel P, Franz B, Bremer B, Suneetha PV, Heim A. Chronic hepatitis E in heart transplant recipients. Am J Transplant 2012;12:3128– 3133.
36. Motte A, Roquelaure B, Galambrun C, Bernard F, Zandotti C, Colson P. Hepatitis E in three immunocompromised children in southeastern France. J ClinVirol 2012;53:162–166.
37. Kaba M, RichetH,Ravaux I, Moreau J, Poizot-Martin I, Motte A, et al. Hepatitis E virus infection in patients infected with the human immunodeficiency virus. J Med Virol 2011;83:1704–1716.
38. Neukam K, Barreiro P, Macías J, Avellón A, Cifuentes C, Martín-Carbonero L, et al. Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin. Clin Infect Dis 2013;57:465–468.
39. Bouamra Y, Gérolami R, Arzouni JP, Grimaud JC, Lafforgue P, Nelli M, et al. Emergence of autochthonous infections with hepatitis E virus of genotype 4 in Europe. Intervirology 2014;57:43–48.
40. Garbuglia AR, Scognamiglio P, Petrosillo N, Mastroiaini CM, Sordillo P, Gentile D, et al. Hepatitis E virus genotype 4 outbreak, Italy, 2011. Emerg Infect Dis 2013;19:110–114.
41. Fogeda M, Avellón A, Cilla CG, Echevarría JM. Imported and autochthonous hepatitis E virus strains in Spain. J Med Virol 2009;81:1743–1749.
42. Rossi-Tamisier M, Moal V, Gerolami R, Colson P. Discrepancy between anti-hepatitis E virus immunoglobulin G prevalence assessed by two assays in kidney and liver transplant recipients. J ClinVirol 2013;56:62–64.
43. Bernal W, Smith HM, Williams R. A community prevalence study on antibodies to hepatitis A and E in inner-city London. J Med Virol 1996;49: 230–234.
44. Ijaz S, Vyse AJ, Morgan D, Pebody RG, Tedder RS, Brown D. Indigenous hepatitis E virus infection in England: more common than it seems. J Clin Virol 2009;44:272–276.
45. Gessoni G, Manoni F. Hepatitis E virus infection in north-eastItaly: serological study in the open population and groups at risk. J Viral Hepat 1996;3:197– 202.
46. Vulcano A, Angelucci M, Candelori E, Martini V, Patti AM, Mancini C, et al. HEV prevalence in the general population and among workers at zoonoticrisk in Latium Region. Ann Ig 2007;19:181–186.
47. Rapicetta M, Kondili LA, Pretolani S, Stroffolini T, Chionne P, Villano U, et al. Seroprevalence and anti-HEV persistence in the general population of the Republic of San Marino. J Med Virol 1999;58:49–53.
48. Buti M, Domínguez A, Plans P, Jardí R, Schaper M, Espuñes J, et al. Community-based seroepidemiological survey of hepatitis E virus infection in Catalonia, Spain. ClinVaccine Immunol 2006;13:1328–1332.
49. Buti M, Plans P, Domínguez A, Jardi R, Rodriguez Frias F, Esteban R, et al. Prevalence of hepatitis E virus infection in children in the Northeast of Spain. Clin Vaccine Immunol 2008;15:732–734.
50. Fogeda M, Avellón A, Echevarría JM. Prevalence of specific antibody to hepatitis E virus in the general population of the Community of Madrid, Spain. J Med Virol 2012;84:71–74.
51. Faber MS, Wenzel JJ, Jilg W, Thamm M, Höhle M, Stark K. Hepatitis E virus seroprevalence among adults, Germany. Emerg Infect Dis 2012;18:1654– 1657.
52. Verhoef F, Koopmans M, Duizer E, Bakker J, Reimerink J, van Pelt W. Seroprevalence of hepatitis E antibodies and risk profile of HEV seropositivity in The Netherlands, 2006–2007. Epidemiol Infect 2012;140:1838–1847.
53. Mansuy J-M, Bendall R, Legrand-Abravanel F, Sauné K,Miédouge M, Ellis V, et al. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 2011;17:2309–2312.
54. Colson P, Borentain P, Queyriaux B, Kaba M, Moal V, Gallian P, et al. Pig liver sausage as a source of hepatitis E virus transmission to humans. J Infect Dis 2010;202:825–834.
55. Wenzel JJ, Preiß J, Schemmerer M, Huber B, Plentz A, Jilg W. Detection of hepatitis E virus (HEV) from porcine livers in Southeastern Germany and high sequence homology to human HEV isolates. J Clin Virol 2011;52:50–54.
56. Di Bartolo I, Díez-Valcarce M, Vasickova P, Kralik P, Hernández M, Angeloni G, et al. Hepatitis E virus in pork production chain in Czech Republic, Italy, and Spain, 2010. Emerg Infect Dis 2012;18:1282–1289.
57. Berto A, Martelli F, Grierson S, Banks M. Hepatitis E virus in pork food chain, United Kingdom, 2009–2010. Emerg Infect Dis 2012;18:1358–1360.
58. Berto A, Grierson S, Hakze-van der Honing R, Martelli F, Johne R, Reetz J, et al. Hepatitis E virus in pork liver sausage, France. Emerg Infect Dis 2013; 19:264–266.
59. Steyer A, Naglič T, Močilnik T, Poljšak-Prijatelj M, Poljak M. Hepatitis E virus in domestic pigs and surface waters in Slovenia: prevalence and molecular characterization of a novel genotype 3 lineage. Infect Genet Evol 2011;11: 1732–1737.
60. Crossan C, Baker PJ, Craft J, Takeuchi Y, Dalton HR, Scobie L. Hepatitis E virus genotype 3 in shellfish, United Kingdom. Emerg Infect Dis 2012;18: 2085–2087.
61. Zhao Q, Zhang J, Wu T, Li SW, Ng MH, Xia NS, et al. Antigenic determinants of hepatitis E virus and vaccine-induced immunogenicity and efficacy. J Gastroenterol 2013;48:159–168.
62. Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010; 376:895–902.
63. Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, Yao X, et al. Protection against hepatitis E virus infection by naturally acquired and vaccine-induced immunity. Clin Microbiol Infect 2013, in press.
64. Tang X, Yang C, Gu Y, Song C, Zhang X, Wang Y, et al. Structural basis for the neutralization and genotype specificity of hepatitis E virus. Proc Natl Acad Sci U S A 2011;108:10266–10271.